The Short Answer
Temporomandibular arthritis (M26.642) is inflammation inside your jaw hinge—the joint where your lower jaw connects to your skull. Uric acid crystals or calcium pyrophosphate crystals trigger immune cells to attack the joint lining, causing swelling, cartilage wear, and pain [1][4].
Your jaw joint (called the TMJ) is a hinge that opens and closes 1,000+ times daily when you chew, talk, and yawn. When arthritis develops, the joint space narrows by 20–40%, and jaw opening drops from normal (40+ mm) to painful and limited (20–30 mm or less) [1][3]. Federal clinical data show that 5–12% of arthritis patients develop TMJ involvement, especially those with gout or juvenile idiopathic arthritis.
Inside the joint, monosodium urate or calcium pyrophosphate crystals lodge in the synovial fluid—the slippery liquid that lubricates the joint. Your immune system mistakes these crystals for invaders and floods the joint with inflammatory cells, releasing enzymes that erode cartilage and bone [1][4]. This is why serum uric acid control (target < 6.0 mg/dL) is so critical: lower uric acid means fewer crystals and less inflammation.
The pain you feel is real inflammation, not just stiffness. Deep aching in the jaw, clicking or popping when you open your mouth, and difficulty chewing hard foods are all signs that the joint cartilage is swollen and the disc (a shock absorber inside the joint) is displaced [3]. The good news: early treatment with anti-inflammatory medication and sometimes a single steroid injection can reverse swelling and restore normal jaw function in 70% of patients within 4 weeks.